Future Cardiology logo Future Medicine logo

Future Cardiology reflects the new era of cardiology and highlights new molecular approaches in advancing cardiovascular therapy. The journal publishes clinical research, commentary and therapeutic overviews highlighting optimal therapy and future options and strategies.

Publisher: Future Medicine

Volume 1, Number 5, September 2005
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

Cathepsins: novel drug targets for cardiovascular diseases?
pp. 563-565(3)
Author: Shi, Guo-Ping

Bulletin Board

Potential association between Helicobacter pylori and increased risk of atrial fibrillation
pp. 567-569(3)

Drug Evaluation

Clinical utility of extended-release niacin: update and summary
pp. 571-578(8)
Authors: Cheung, Rebecca J; Ito, Matthew K

Clopidogrel: cardiologists’ panacea or neurologists’ headache?
pp. 579-590(12)
Authors: Bezerra, Daniel C; Bogousslavky, Julien

Valsartan: the past, present and future
pp. 591-598(8)
Authors: Køber, Lars; Torp-Pedersen, Christian

Priority Paper Evaluation

Implications and problems of the Sudden Cardiac Death in Heart Failure Trial
pp. 599-603(5)
Authors: Shimizu, Wataru; Satomi, Kazuhiro

Clopidogrel plus aspirin in patients with acute myocardial infarction treated with fibrinolytic therapy – CLARITY-TIMI 28
pp. 605-610(6)
Author: Ferguson, James J

Conference Scene

International Conference of Nuclear Cardiology
pp. 611-612(2)
Authors: De Winter, Olivier; De Bondt, Pieter

12th World Congress on Heart Disease – new trends in research, diagnosis and treatment
pp. 613-616(4)
Author: Bowles, Neil E

Perspective

Coronary heart disease in women: what do we know now?
pp. 617-628(12)
Author: Duvernoy, Claire S

Refractory myocardial ischemic syndromes: patients’ characterization and treatment goals
pp. 629-635(7)
Authors: Kornowski, Ran; Fuchs, Shmuel; Zafrir, Nili

Review

Myocardial ischemia and coronary microvascular vasomotion: the impact of hypercholesterolemia
pp. 637-647(11)
Authors: Komaru, Tatsuya; Shirato, Kunio

The use of MCP-1 and soluble CD40 ligand in a pathophysiology-guided approach to the management of coronary artery disease
pp. 649-656(8)
Authors: Mo, Vivian Y; de Lemos, James A

Lipopolysaccharide, CD14 and Toll-like receptors: an emerging link between innate immunity and atherosclerotic disease
pp. 657-674(18)
Authors: Shimada, Kazunori; Daida, Hiroyuki; Ma-Krupa, Wei; Goronzy, Jörg J; Weyand, Cornelia M

The therapeutic potential of immune therapy in idiopathic dilated cardiomyopathy
pp. 675-682(8)
Authors: Mobini, Reza; Andersson, Bert

Emerging treatments for viral myocarditis
pp. 683-692(10)
Author: Matsumori, Akira

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A